Keep up to date with the latest news delivered direct to your Inbox.
Breast Cancer Drug Trialled In Cornwall "Unprecedented"
8:13am 29th September 2014
(Updated 8:13am 29th September 2014)
Doctors at Treliske say the results of a new breast cancer drug are "unprecedented."
Cornish patients took part in a trial of Perjeta.
It works by blocking signals that make the tumour more agressive.
Now experts say it can extend the life of women with advanced forms of the diesease by an average of almost 16 months.
Used in conjunction with Herceptin and chemotherapy scientists say it can give HER2-positive women another five years.
But the watchdog has already said it thinks it is too expensive for the NHS.
Dr Duncan Wheatley from the Royal Cornwall Hospital said: "These results are unprecedented.
"Never before in advanced breast cancer have we seen a treatment with such a huge survival benefit, let alone in this particular sub-type of breast cancer which is regarded as being difficult-to-treat with a poor prognosis.
“The strategy of combining two HER2-targeted antibodies with complementary mechanisms of action means that we can control the cancer and extend survival for significantly longer than ever before, while minimising the toxicity. This marks a significant step forward in the fight against the disease and something that should be celebrated.”
Professor David Miles, Consultant Medical Oncologist, lead the study. He said: "These results are impressive. They show a magnitude of survival benefit which we have never seen before in advanced breast cancer, let alone this particular type, previously regarded as having a poor prognosis and being difficult to treat.
“The introduction of Herceptin made a huge difference for our patients but this strategy of combining Herceptin with this second HER2-targeted antibody with complementary mechanisms, means that we are able to control the cancer and prolong survival for even longer.
"The observation that women with HER2-positive metastatic breast cancer can live alongside their disease for so many years is frankly unprecedented. These data represent a significant step forward in the fight against breast cancer with combination therapies such as this paving the way for cancer treatments in the future.”
Share This StoryTweet
Murder probe after man stabbed to death on bus
National News: A man has been stabbed to death on the upper deck of a bus in the West Midlands.
Business Cornwall News - Friday, 18th December 2015
Business Cornwall News: Cornwall is spearheading reform of the Uk’s business licensing laws following a a year-long project.
The Last Jedi: Name of Star Wars episode VIII revealed online
Showbiz News: The name for the hotly anticipated next installment of the Star Wars film franchise has been revealed as The Last Jedi.
Microplastics in seafood could be a health risk, experts fear
World News: Seafood eaters are absorbing tiny pieces of plastic into their bloodstream with unknown effects on their health, according to research exclusively shown to Sky News.
Bernie Ecclestone no longer in charge of F1
Sports News: Bernie Ecclestone is no longer in charge of Formula One (F1) after almost 40 years in the driving seat.
Finally! After years of trying, China celebrates ballpoint pen breakthrough
Strange News: China has finally produced its own fully home-produced ballpoint pen after years of trying to master the complex techniques involved in making the delicate tips.